Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Capital Expenditures: 2019-2025

Historic Capital Expenditures for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $42,000.

  • IDEAYA Biosciences' Capital Expenditures fell 90.81% to $42,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 12.69%. This contributed to the annual value of $3.9 million for FY2024, which is 62.88% up from last year.
  • Latest data reveals that IDEAYA Biosciences reported Capital Expenditures of $42,000 as of Q3 2025, which was down 93.67% from $663,000 recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Capital Expenditures ranged from a high of $1.8 million in Q2 2022 and a low of $42,000 during Q3 2025.
  • For the 3-year period, IDEAYA Biosciences' Capital Expenditures averaged around $750,909, with its median value being $746,000 (2023).
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 2,939.39% in 2021, then slumped by 90.81% in 2025.
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' Capital Expenditures stood at $605,000 in 2021, then skyrocketed by 140.39% to $1.1 million in 2022, then plummeted by 45.23% to $838,000 in 2023, then skyrocketed by 31.50% to $1.1 million in 2024, then slumped by 90.81% to $42,000 in 2025.
  • Its Capital Expenditures was $42,000 in Q3 2025, compared to $663,000 in Q2 2025 and $1.3 million in Q1 2025.